End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 CNY | -1.97% | +4.74% | +6.99% |
Apr. 30 | Kangmei Pharmaceutical Logs Profit in Q1 | MT |
Apr. 29 | Kangmei Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
All sales are earned in China.
Number of employees: 4,409
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chinese Medicine
47.8
%
| 1,906 | 45.6 % | 2,332 | 47.8 % | +22.33% |
Western Medicine
29.6
%
| 1,415 | 33.9 % | 1,441 | 29.6 % | +1.85% |
Health Food and Food
10.3
%
| 325 | 7.8 % | 503 | 10.3 % | +54.90% |
Property Rental and Sale and Others
9.2
%
| 403 | 9.6 % | 448 | 9.2 % | +11.06% |
Medical Instruments
2.1
%
| 112 | 2.7 % | 103 | 2.1 % | -8.14% |
Other Business
1.0
%
| 19 | 0.5 % | 47 | 1.0 % | +149.66% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 4,180 | 100.0 % | 4,874 | 100.0 % | +16.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Guo Wei Liu
CEO | Chief Executive Officer | 51 | 20-10-09 |
Gui Bo Gong
DFI | Director of Finance/CFO | 50 | 20-10-09 |
Min Li
IRC | Investor Relations Contact | 35 | 18-12-31 |
Yun Feng Zhou
SEC | Corporate Secretary | 43 | 20-10-13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Ping Lai
BRD | Director/Board Member | 63 | 20-10-29 |
Yan Zhu Gao
CHM | Chairman | 59 | 20-10-29 |
Qi Mi
BRD | Director/Board Member | 62 | 22-01-24 |
Guo Wei Liu
CEO | Chief Executive Officer | 51 | 20-10-09 |
Gui Bo Gong
DFI | Director of Finance/CFO | 50 | 20-10-09 |
Tao Luo
BRD | Director/Board Member | 51 | 22-01-24 |
Jun Liang
BRD | Director/Board Member | 40 | 22-01-24 |
Zhi Jian Lai
CHM | Chairman | 55 | 22-01-24 |
Long Tao Huang
BRD | Director/Board Member | 42 | 22-01-24 |
Qing Zeng
BRD | Director/Board Member | 60 | 22-01-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,939,793,690 | 9,424,440,954 ( 67.61 %) | 75,927,000 ( 0.5447 %) | 67.61 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
413,734,278 | 3.04% | 124,219,580 $ |
Company contact information
Kangmei Pharmaceutical Co., Ltd.
Xiameilin Taike Road Futian District
518000, Shenzhen
+86 755 3318 7777
http://www.kangmei.com.cnSector
Sales per Business
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.99% | 3.81B | |
+33.25% | 699B | |
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.81% | 236B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- 600518 Stock
- Company Kangmei Pharmaceutical Co., Ltd.